相关实验视频
Updated: Jan 29, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.2K
迷你青春期的性腺激素:男性先天性性阴性腺症的病理生理和治疗影响
Ignazio Cammisa1, Donato Rigante1,2, Clelia Cipolla1
1Department of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Children (Basel, Switzerland)
|January 28, 2026
概括
在患有先天性阴阳性阴阳性特异性阴阳性特异性阴阳性特异性阴阳性特异性 (CHH) 的男性婴儿中,早期的阴阳性特异性疗法安全地复制了迷你青春期的荷尔蒙激增. 这种治疗促进生殖器生长和丸发育,改善生殖潜力.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 生殖医学 生殖医学
- 发展生物学 发展生物学
背景情况:
- 迷你青春期是一个关键的产后激素激增,对男性生殖发育至关重要.
- 先天性性性性性性 (CHH) 的特点是,小青春期的荷尔蒙激增变得淡或不存在.
- CHH可能导致小阴茎,密码性,以及损伤的塞尔托利细胞增殖.
研究的目的:
- 审查早期性腺激素治疗对患有CHH的男性婴儿的影响.
- 总结这一干预措施对生物化学和临床结果的证据.
主要方法:
- 对接受淋巴激素治疗的CHH男性婴儿研究的综合文献综述.
- 生物化学标志物的分析 (LH,FSH,丸激素,抑制素B,AMH) 和临床措施 (阴茎长度,丸体积,丸下降).
主要成果:
- 早期的淋巴激素治疗使荷尔蒙水平正常化,增加了丸激素,B抑制素和AMH.
- 在阴茎长度,丸体积和丸下降方面观察到显著的改善.
- 连续和间歇治疗方案都有效;治疗耐受性良好,没有严重的不良事件.
结论:
- 早期淋巴激素治疗是一种安全有效的方法,可以模仿CHH男性婴儿的生理迷你青春期.
- 这种干预措施支持生殖器发育,并可能改善未来的生殖结果.
- 需要进一步的纵向研究来评估对青春期和生育能力的长期影响.
相关概念视频
Signs of Puberty
1.5K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.5K
Infertility in Males
560
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
560
Pneumonia II: Pathophysiology
2.8K
The pathophysiology of pneumonia involves the following steps:
2.8K
Pathophysiology of Diabetes
3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.5K
Hypertension II: Pathophysiology
915
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
915
Pathophysiology of Vomiting
3.0K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.0K

